Latest Publications

Share:

Trends in Dutch public M&A 2024

Our latest report delves into the key trends and noticeable events that have shaped the dynamic Dutch public M&A landscape from January 1, 2023 to November 12, 2024. Key trends we want to highlight are: 1. Low deal...more

Global M&A Insights: Deal-making predictions for 2024

Welcome to our year-end edition of M&A Insights, where we preview some of the themes we expect to shape deal-making over the next 12 months. Continued volatility in the debt markets has resulted in another subdued year for...more

Trends in Dutch Public M&A 2023

The outlook for public M&A remains challenging, even if we have now reached a plateau in interest rates. We see two primary areas for opportunity: (i) strategic buyers using the current conditions to accelerate...more

Trends in Dutch Public M&A 2022

The deal environment in the near future is likely to be challenging but we also see a substantial number of drivers for public takeovers such as strategic combinations when consolidation makes sense or is inevitable,...more

M&A Insights H1 2022

There has been an explosion of interest in the growth capital market in recent years, with numerous new investors raising billions of dollars for investment in earlier stage companies positioned for expansion. ...more

Trends in Dutch public M&A: Resilience in times of Covid-19

Our 2020 - H1 2021 report offers insight into developments and trends in the Dutch public M&A market based on our continued involvement in over 80% of public offers for Euronext Amsterdam listed companies since 2015....more

European Medicines Agency heads for Amsterdam

Today the 27 member states of the European Union have decided on Amsterdam as the new home of the European Medicines Agency. The decision came after three rounds of voting, with Amsterdam eventually emerging the winner after...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide